Протективный потенциал ингибиторов натрий-глюкозного котранспортера 2 типа в клинике внутренних болезней (часть 2)

Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are now uncovering new possibilities in the field of internal medicine owing to their diverse protective effects. In the second part of the literature review, we explore potential applications of SGLT2i in hepatology, neurology, ophthalmology, and oncology, mechanisms of action of such drugs as dapagliflozin, empagliflozin, canagliflozin, etc, and their effect on different organs and systems. © Ashot A. Avagimyan, Mohammad Sheibani, Artem I. Trofimenko, Evgenii E. Lysov, Farida M. Khamidova, Anahit Z. Aznauryan, Lilit M. Sukiasyan, Karmen T. Sahakyan, Tamara R. Gevorgyan, Marina R. Tatoyan, Gayane L. Mkrtchyan, Goharik L. Meltonyan, Anna R. Petrosyan, Ludmila A. Martemyanova, Ruzanna R. Petrosyan, Olga I. Urazova, Nana V. Pogosova, Nizal Sarrafzadegan.

Authors
Avagimyan A.A. , Sheibani M. , Trofimenko A.I. , Lysov E.E. , Khamidova F.M. , Aznauryan A.Z. , Sukiasyan L.M. , Sahakyan K.T. , Gevorgyan T.R. , Tatoyan M.R. , Mkrtchyan G.L. , Meltonyan G.L. , Petrosyan A.R. , Martemyanova L.A. , Petrosyan R.R. , Urazova O.I. , Pogosova N.V. , Sarrafzadegan N.
Journal
Innovacionnaâ medicina Kubani
Publisher
Научно-исследовательский институт - Краевая клиническая больница № 1 им. проф. С.В. Очаповского
Number of issue
1
Language
English
Pages
101-109
Status
Published
Link
External link
DOI
10.35401/2541-9897-2025-10-1-101-109
Volume
10
Year
2025
Organizations
  • 1 Yerevan State Medical University after M. Heratsi, Yerevan, Armenia
  • 2 Iran University of Medical Sciences, Tehran, Iran
  • 3 Kuban State Medical University, Krasnodar, Russian Federation
  • 4 Samarkand State Medical University, Samarkand, Uzbekistan
  • 5 Gomel State Medical University, Gomel, Belarus
  • 6 Lebanese American University, Beirut, Lebanon
  • 7 Siberian State Medical University, Tomsk, Russian Federation
  • 8 National Medical Research Centre of Cardiology after Acad. E.I. Chazov, Moscow, Russian Federation
  • 9 Patrice Lumumba Peoples' Friendship University of Russia, Moscow, Russian Federation
  • 10 Isfahan Cardiovascular Research Centre, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Keywords
canagliflozin; dapagliflozin; empagliflozin; hepatoprotection; neuroprotection; oncoprotection; retinoprotection
Cite
ГОСТ MLA RIS BibTex
Share

Other records

EVOLUTION OF INNER CRUSTAL DISPLACEMENT DEFICIT ACCORDING TO THE GPS DATA IN CONNECTION WITH SEISMICITY IN THE PERIOD OF 2014-2024 AND THE MW=7.4 HUALIEN EARTHQUAKE, TAIWAN; [ЭВОЛЮЦИЯ ДЕФИЦИТА ВНУТРЕННИХ СМЕЩЕНИЙ ЗЕМНОЙ КОРЫ ПО ДАННЫМ GPS В СВЯЗИ С СЕЙСМИЧНОСТЬЮ 2014-2024 ГГ. И ЗЕМЛЕТРЯСЕНИЕМ ХУАЛЯНЬ, ТАЙВАНЬ (МW=7.4)]

Article
Kaftan V.I., Melnikov A.Yu., Dokukin P.A.
Геодинамика и тектонофизика. Институт земной коры СО РАН, Сибирское отделение РАН. Vol. 16. 2025.